Reactions to infliximab in patients with rheumatoid arthritis.
Grigorios T
GT
Sakellariou
Ioannis
I
Chatzigiannis
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab